The Experts below are selected from a list of 5676 Experts worldwide ranked by ideXlab platform

Markku Miettinen - One of the best experts on this subject based on the ideXlab platform.

  • Comprar Modern Soft Tissue Pathology. Tumors And Non-Neoplastic Conditions 2nd Ed. | Markku Miettinen | 9781107567276 | Cambridge University Press
    2016
    Co-Authors: Markku Miettinen
    Abstract:

    Tienda online donde Comprar Modern Soft Tissue Pathology. Tumors And Non-Neoplastic Conditions 2nd Ed. al precio 267,12 € de Markku Miettinen, tienda de Libros de Medicina, Libros de Anatomia - Anatomia

  • comprar modern Soft Tissue Pathology tumors and non neoplastic conditions 2nd ed markku miettinen 9781107567276 cambridge university press
    2016
    Co-Authors: Markku Miettinen
    Abstract:

    Tienda online donde Comprar Modern Soft Tissue Pathology. Tumors And Non-Neoplastic Conditions 2nd Ed. al precio 267,12 € de Markku Miettinen, tienda de Libros de Medicina, Libros de Anatomia - Anatomia

  • modern Soft Tissue Pathology
    2014
    Co-Authors: Markku Miettinen
    Abstract:

    Modern Soft Tissue Pathology : , Modern Soft Tissue Pathology : , کتابخانه دیجیتالی دانشگاه علوم پزشکی و خدمات درمانی شهید بهشتی

  • Modern Soft Tissue Pathology: ATYPICAL LIPOMATOUS TUMOR AND LIPOSARCOMAS
    2010
    Co-Authors: Markku Miettinen
    Abstract:

    Atypical lipomatous tumors and four clinicopathologically or genetically distinct types of liposarcomas, sarcomas with fatty differentiation, are discussed in this chapter. Table 15.1 reviews their clinicopathologic features. The diagnosis of liposarcoma is based on recognition of adipocytic atypia and the characteristic histologic patterns for each type of liposarcoma. Fat stains are not useful, because fat is present in other tumors, for example in malignant fibrous histiocytoma (MFH, undifferentiated sarcoma) and in nonsarcomatous tumors, such as renal cell carcinoma. Immunostains are of limited value. The present classification of liposarcoma has evolved especially by work by Enterline et al., Enzinger et al., and Evans. Well-differentiated liposarcoma and atypical lipomatous tumor are considered synonymous in the World Health Organization (WHO) classification. In this text, however, their clinical discussion is separated so that subcutaneous lesions are designated as atypical lipomatous tumors, whereas morphologically similar intramuscular, inguinal, mediastinal, and intraabdominal (retroperitoneal) tumors are designated as well-differentiated liposarcomas because of their greater tendency to uncontrollable local recurrences and dedifferentiation. The latter refers to their evolution into a nonlipomatous sarcoma phenotype. Despite some tendencies for different morphology in subcutaneous versus deep tumors, there are no criteria that could morphologically distinguish an atypical lipomatous tumor from a well-differentiated liposarcoma. Both types are characterized by 12q13–15 amplification; this genomic segment includes genes such as murine double minute (MDM2). Dedifferentiated liposarcoma is a transformed variant of well-differentiated liposarcoma, representing its histologic and biologic disease progression. This type is most common in the retroperitoneum.

  • Modern Soft Tissue Pathology: HEMANGIOMAS, LYMPHANGIOMAS, AND REACTIVE VASCULAR PROLIFERATIONS
    2010
    Co-Authors: Markku Miettinen
    Abstract:

    Benign vascular tumors and tumor-like conditions include a wide variety of clinicopathologic entities, among them different types of hemangiomas, vascular malformations, teleangiectasiae, hemangioma-like reactive vascular proliferations, and lymphangiomas. Also included in this discussion is kaposiform hemangioendothelioma, a hemangioma variant without metastatic potential (although one having potential for fatal complications through thrombocytopenia). The discussion of specific tumor entities is preceded by a synopsis of endothelia and angiogenesis given for biologic background information relevant for vascular tumors. The genetic background of inheritable hemangiomas and vascular malformations is becoming known from the hereditary syndromes, but the somatic genetics of hemangiomas is still poorly understood. Borderline (hemangioendotheliomas) and malignant vascular tumors (angiosarcoma) are discussed in Chapter 22. Hemangiopericytoma is considered related to solitary fibrous tumors, and these tumors are discussed together (Chapter 12). Vascular smooth muscle tumors, vascular leiomyoma and leiomyosarcoma, are discussed with other smooth muscle tumors (Chapter 16), and lymphangiomyoma is included among PEComas (Chapter 19). Glomus tumor and angiomyopericytoma have significant vascular components while also containing smooth muscle–related elements (Chapter 23). Biology of Endothelia and Angiogenesis Endothelial cells are mesenchymal cells that not only form a protective epithelial-like inner lining in the lumen of the blood vessels and lymphatics but also have several other vasoregulatory functions. These include regulation of vascular permeability and caliber, transport of metabolites (e.g., cholesterol), and regulation of leukocyte adhesion, trafficking, and hemostasis. External signals from growth factors/cytokines secreted by a variety of cells modulate the differentiation, antigen expression, and functional state of endothelial cells.

Andrew Horvai - One of the best experts on this subject based on the ideXlab platform.

  • Comprar Bone And Soft Tissue Pathology. High-Yield Pathology (Online And Print) | Andrew Horvai | 9781437725209 | Saunders
    2012
    Co-Authors: Andrew Horvai
    Abstract:

    Tienda online donde Comprar Bone And Soft Tissue Pathology. High-Yield Pathology (Online And Print) al precio 168,00 € de Andrew Horvai, tienda de Libros de Medicina, Libros de Patologia - Patologia

  • comprar bone and Soft Tissue Pathology high yield Pathology online and print andrew horvai 9781437725209 saunders
    2012
    Co-Authors: Andrew Horvai
    Abstract:

    Tienda online donde Comprar Bone And Soft Tissue Pathology. High-Yield Pathology (Online And Print) al precio 168,00 € de Andrew Horvai, tienda de Libros de Medicina, Libros de Patologia - Patologia

  • bone and Soft Tissue Pathology
    2012
    Co-Authors: Andrew Horvai, Thomas M Link
    Abstract:

    I. BONE AND JOINT A. Metabolic Conditions Paget Disease Osteoporosis Osteomalacia Rickets Osteogenesis Imperfecta Hyperparathyroidism Serous Fat Atrophy Xanthomatosis Osteopetrosis Ochronosis Melorheostosis Gaucher Disease B. Infectious and Inflammatory Conditions Osteoarthritis Rheumatoid Arthritis Septic Arthritis Gout Other Crystal-Induced Synovitis and Calcium Deposition Acute Osteomyelitis Chronic Osteomyelitis Osteonecrosis Bone Fracture and Fracture Callus C. C ystic Lesions Aneurysmal Bone Cyst Unicameral Bone Cyst Intraosseous Ganglion D. Giant Cell-Rich Lesions Giant Cell Tumor Giant Cell-Reparative Granuloma Brown Tumor Tenosynovial Giant Cell Tumor, Localized Type Tenosynovial Giant Cell Tumor, Diffuse Type E. Mixed Periosteal Lesions Bizarre Parosteal Osteochondromatous Proliferation Subungual Exostosis Florid Reactive Periostitis F. C artilage-Forming Lesions Solitary Osteochondroma Multiple Hereditary Exostoses Enchondroma Multiple Chondroma Syndromes (Ollier Disease, Maffucci Syndrome) Periosteal Chondroma Synovial Chondromatosis Chondro-Osseous Loose Body Chondromyxoid Fibroma Chondroblastoma Conventional Intramedullary Chondrosarcoma Chondrosarcoma of the Small Bones of the Hands and Feet Periosteal Chondrosarcoma Secondary Chondrosarcoma Clear Cell Chondrosarcoma Dedifferentiated Chondrosarcoma Mesenchymal Chondrosarcoma G. B one-Forming Lesions Bone Island Osteoid Osteoma Osteoblastoma Conventional Osteosarcoma Small Cell Osteosarcoma Telangiectatic Osteosarcoma High-Grade Surface Osteosarcoma Post-Treatment Osteosarcoma Parosteal Osteosarcoma Periosteal Osteosarcoma Low-Grade Central Osteosarcoma Chondroblastoma-Like Osteosarcoma H. N otochordal Tumors Benign Notochordal Cell Tumor Chordoma I. F ibrous Lesions Fibrous Dysplasia Osteofibrous Dysplasia Desmoplastic Fibroma Nonossifying Fibroma Ossifying Fibroma J. Vascular Lesions Hemangioma Synovial Hemangioma Epithelioid Hemangioma Epithelioid Hemangioendothelioma Angiosarcoma of Bone Massive Osteolysis K. E wing Sarcoma L. H ematopoietic Lesions Primary Osseous Lymphoma Acute Myeloid Leukemia Plasmacytoma Langerhans Cell Histiocytosis Mastocytosis M. Undifferentiated Pleomorphic Sarcoma of Bone N. Adamantinoma O. L ipomatous Tumors Intraosseous Lipoma Synovial Lipomatosis P. C arcinoma Metastatic Carcinoma Squamous Cell Carcinoma Arising in a Draining Sinus of Chronic Osteomyelitis II. Soft Tissue A. Inflammatory and Pseudosarcomatous Myofibroblastic Proliferations Nodular Fasciitis Proliferative Myositis and Proliferative Fasciitis Ischemic Fasciitis Postoperative Spindle Cell Nodule Necrotizing Fasciitis B. F ibrosing Lesions and Fibromatoses Elastofibroma Desmoplastic Fibroblastoma Hypertrophic Scar Keloid Fibrous Hamartoma of Infancy Gardner Fibroma Nuchal Fibroma Fibromatosis Colli Calcifying Aponeurotic Fibroma Fibroma of Tendon Sheath Superficial Fibromatosis Deep Fibromatosis Inclusion-Body Fibroma IgG4-Related Sclerosing Disease C. Myofibroblastic Tumors Myofibroblastoma (Mammary Type) Inflammatory Myofibroblastic Tumor Myofibroma and Myofibromatosis Intranodal Myofibroblastoma Myofibroblastic Sarcoma D. Periva scular Tumors Glomus Tumor Glomuvenous Malformation Myopericytoma E. F ibroblastic and Fibrohistiocytic Tumors Reticulohistiocytoma Juvenile Xanthogranuloma Benign Fibrous Histiocytoma Angiomatoid Fibrous Histiocytoma Plexiform Fibrohistiocytic Tumor Superficial Acral Fibromyxoma Superficial Angiomyxoma Dermatofibrosarcoma Protuberans Giant Cell Fibroblastoma Fibrosarcoma Arising in DermatofibrosarcomaProtuberans Adult Fibrosarcoma Infantile Fibrosarcoma Sclerosing Epithelioid Fibrosarcoma Low-Grade Fibromyxoid Sarcoma Atypical Fibroxanthoma Intramuscular Myxoma Myxofibrosarcoma F. Adipose Tumors Lipoblastoma Lipoma and Lipomatosis Angiolipoma Neural Fibrolipoma Hibernoma Chondroid Lipoma Spindle Cell and Pleomorphic Lipoma Well-Differentiated Liposarcoma and Atypical Lipomatous Tumor Dedifferentiated Liposarcoma Myxoid and Round Cell Liposarcoma Pleomorphic Liposarcoma G. S mooth Muscle Tumors Angioleiomyoma Pilar Leiomyoma Leiomyoma of Deep Soft Tissue Leiomyosarcoma of Soft Tissue Vascular Leiomyosarcoma Epstein-Barr Virus-Associated Smooth Muscle Tumor H. Genital Stromal Tumors Fibroepithelial Polyp Angiomyofibroblastoma Cellular Angiofibroma Aggressive Angiomyxoma I. S keletal Muscle Tumors Adult Rhabdomyoma Fetal Rhabdomyoma Genital Rhabdomyoma Alveolar Rhabdomyosarcoma Embryonal Rhabdomyosarcoma Pleomorphic Rhabdomyosarcoma J. N erve and Nerve Sheath Tumors Traumatic Neuroma Schwannoma Ancient Schwannoma Ganglioneuroma Neurothekeoma Cellular Schwannoma Neurofibroma Plexiform Neurofibroma Palisaded Encapsulated Neuroma Perineurioma Malignant Peripheral Nerve Sheath Tumor Malignant Triton Tumor Granular Cell Tumor Malignant Granular Cell Tumor Neuroglial Heterotopia Neuroblastoma Esthesioneuroblastoma Paraganglioma Melanotic Neuroectodermal Tumor of Infancy K. Vascular Tumors Papillary Endothelial Hyperplasia Pyogenic Granuloma Arteriovenous Malformation Capillary Hemangioma Cavernous Hemangioma Lymphangioma Epithelioid Hemangioma Kimura Disease Spindle Cell Hemangioma Sinusoidal Hemangioma Epithelioid Hemangioendothelioma Hobnail Hemangioendothelioma Angiosarcoma Intimal Sarcoma Kaposi Sarcoma Kaposiform Hemangioendothelioma L. B one and Cartilage Tumors of Soft Tissue Soft Tissue Chondroma Extraskeletal Myxoid Chondrosarcoma Nuchal Fibrocartilaginous Pseudotumor Myositis Ossificans Ossifying Fibromyxoid Tumor Soft Tissue Osteosarcoma M. Periva scular Epithelioid Cell Neoplasms N. T umors of Uncertain Lineage Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts Soft Tissue Myoepithelioma Alveolar Soft Part Sarcoma Clear Cell Sarcoma Synovial Sarcoma Extrarenal Rhabdoid Tumor Epithelioid Sarcoma (Proximal and Distal) Desmoplastic Small Round Cell Tumor Primitive Neuroectodermal Tumor (Ewing Sarcoma) Giant Cell Tumor of Soft Tissue Undifferentiated Pleomorphic Sarcoma Phosphaturic Mesenchymal Tumor Myxoinflammatory Fibroblastic Sarcoma Ectopic Hamartomatous Thymoma Solitary Fibrous Tumor and Hemangiopericytoma

Andrew L. Folpe - One of the best experts on this subject based on the ideXlab platform.

  • “Hey! Whatever happened to hemangiopericytoma and fibrosarcoma?” An update on selected conceptual advances in Soft Tissue Pathology which have occurred over the past 50 years
    Human Pathology, 2020
    Co-Authors: Andrew L. Folpe
    Abstract:

    Hemangiopericytoma and fibrosarcoma represented at one time two of the most common diagnoses in Soft Tissue Pathology. Both terms are now largely extinct. This article will review the clinicopathologic, immunohistochemical and molecular genetic advances that have led to these changes, and review the pathologic features of a select group of Soft Tissue tumors previously classified as hemangiopericytoma or fibrosarcoma.

  • Ancillary Diagnostic Tests in the Diagnosis of Cutaneous Soft Tissue Neoplasms
    Soft Tissue Tumors of the Skin, 2019
    Co-Authors: Andrew L. Folpe
    Abstract:

    This chapter will cover selected applications of immunohistochemistry (IHC) in the diagnosis of Soft Tissue tumors of the skin. This section will emphasize applications of IHC to common differential diagnoses in cutaneous Soft Tissue Pathology, including (1) pleomorphic spindle cell tumors; (2) epithelioid malignant neoplasms; (3) monomorphic spindle cell tumors; (4) “fibrohistiocytic” or “histiocytoid” lesions; (5) small, round blue cell tumors; and (6) adipocytic tumors. It is not possible in this relatively brief section to provide a detailed discussion of each antigen or of every rare Soft Tissue tumor that may occasionally be seen in the skin, and the reader is referred to the relevant chapters in this book for more detailed discussions of specific entities.

  • bone and Soft Tissue Pathology
    2010
    Co-Authors: Andrew L. Folpe, Carrie Y Inwards
    Abstract:

    Bone and Soft Tissue Pathology: A Volume in the Diagnostic Pathology Series, by Andrew L. Folpe, MD and Carrie Y. Inwards, MD, packs today's most essential bone and Soft Tissue Pathology know-how into a compact, high-yield format! The book's pragmatic, well-organized approach-complemented by abundant full-color, high-quality illustrations and at-a-glance tables-makes it easy to access the information you need to quickly and accurately identify Pathology specimens. Best of all, Expert Consult functionality provides online access to the full text of the book, downloadable illustrations for your personal use, and more. The result is a practical, affordable reference for study and review as well as for everyday clinical practice. Includes access to the complete contents online, fully searchable, downloadable illustrations for your personal use, and more, allowing you to consult the text a quick, convenient manner. Reviews normal histology before examining abnormal findings, enabling you to conveniently compare their characteristics in one place at one time. Covers both neoplastic and non-neoplastic conditions of bone and Soft Tissue to equip you to meet a wide range of diagnostic challenges. Uses a consistent, user-friendly format to explore each entity's clinical features, pathologic features (gross and microscopic), ancillary studies, differential diagnoses, and prognostic and therapeutic considerations...making it easy to locate specific information on a particular entity. Features abundant boxes and tables throughout that enhance the presentation and accessibility of the material. Offers nearly 1,000 full-color, high-quality illustrations that demonstrate the key features of a wide variety of pathologic lesions to facilitate greater accuracy in identification of specimens. The Foundations in Diagnostic Pathology Series answers the call for fresh, affordable, and easy-to-use guidance. Each region-specific volume provides all of the most essential information on the pathologic entities encountered in practice. Series Editor: John R. Goldblum, MD, FACP, FASCP, FACG Your purchase entitles you to access the web site until the next edition is published, or until the current edition is no longer offered for sale by Elsevier, whichever occurs first. Elsevier reserves the right to offer a suitable replacement product (such as a downloadable or CD-ROM-based electronic version) should access to the web site be discontinued.

  • Comprar Bone and Soft Tissue Pathology. A Volume in the Foundations in Diagnostic Pathology Series, Expert Consult - Online and Print | Andrew L. Folpe | 9780443066887 | Saunders
    2009
    Co-Authors: Andrew L. Folpe
    Abstract:

    Tienda online donde Comprar Bone and Soft Tissue Pathology. A Volume in the Foundations in Diagnostic Pathology Series, Expert Consult - Online and Print al precio 178,50 € de Andrew L. Folpe, tienda de Libros de Medicina, Libros de Patologia - Patologia

  • Consultative (expert) second opinions in Soft Tissue Pathology. Analysis of problem-prone diagnostic situations.
    American Journal of Clinical Pathology, 2001
    Co-Authors: Zoya K. Arbiser, Andrew L. Folpe, Sharon W. Weiss
    Abstract:

    We reviewed 500 consecutive Soft Tissue lesions referred for expert consultation to determine types of lesions and/or situations in which major discrepancies occur. Of 266 cases (53.2%) accompanied by a diagnosis, essential agreement with the second opinion was noted in 68%, minor discrepancy in 7%, and major discrepancy in 25%. The 65 major discrepancies were distributed proportionally to the referring sources and could be divided into 4 groups: benign mesenchymal lesions diagnosed as sarcomas (45%), sarcomas diagnosed as benign tumors (23%), nonmesenchymal lesions diagnosed as sarcoma (20%), and major grading discrepancies (12%). Relatively few lesions accounted for a major proportion of major discrepancies. Problematic lesions were lipoma and fasciitis and their variants and desmoplastic-neurotropic melanoma. Needle biopsy specimens were somewhat more likely to be associated with a discrepant opinion. With the exception of nonmesenchymal lesions, the diagnosis for all major discrepant cases could be made on the basis of the H&E-stained slides, suggesting that failure to perform immunostains did not account for discrepancies. Lack of familiarity with rare or unusual lesions is probably more significant in explaining diagnostic discrepancies than is the increasing use of needle biopsy or the failure to perform immunohistochemical analysis.

Ignac Fogelman - One of the best experts on this subject based on the ideXlab platform.

  • potential role of multislice spect ct in impingement syndrome and Soft Tissue Pathology of the ankle and foot
    Nuclear Medicine Communications, 2013
    Co-Authors: Sugam Chicklore, Gopinath Gnanasegaran, Sanjay Vijayanathan, Ignac Fogelman
    Abstract:

    INTRODUCTION Impingement syndrome and Soft-Tissue Pathology have been recognized as significant causes of chronic ankle pain. Conventional bone scintigraphy was traditionally used for osseous Pathology, but with the advent of single photon emission computed tomography/computed tomography (SPECT/CT) the role of bone scintigraphy in these patients is being reconsidered. AIM The aim of this study was to assess the potential role of multislice SPECT/CT in diagnosing impingement syndrome and Soft-Tissue Pathology of the ankle and foot. MATERIALS AND METHODS A total of 209 patients (age range: 19-80 years) underwent a two-phase Tc-99m methylene diphosphonate bone scan followed by SPECT/CT between 2006 and 2009 for various ankle and foot pathologies. These scans were reviewed for impingement syndrome and Soft-Tissue Pathology. The diagnosis made on SPECT/CT was compared with the clinical diagnosis, and two-phase bone scan findings and additional findings obtained from SPECT/CT were noted. RESULTS Out of the 209 patients, 43 (21%) were diagnosed with impingement syndrome or Soft-Tissue Pathology. Clinical diagnosis versus bone SPECT/CT: in 24/43 (56%) patients, SPECT/CT provided information not suspected on clinical diagnosis. In 19/43 (44%) patients, SPECT/CT confirmed the clinical diagnosis. Two-phase bone scan versus SPECT/CT: in 31/43 (72%) patients, SPECT/CT provided additional information, which was not diagnosed on the conventional two-phase bone scan. The findings of the two-phase bone scan and SPECT/CT were concordant in 12/43 (28%) patients. CONCLUSION Tc-99m methylene diphosphonate bone SPECT/CT is useful in localizing and characterizing impingement syndrome and Soft-Tissue Pathology in patients with ankle/foot pain. SPECT/CT may complement MRI and ultrasonography in the investigation of impingement syndrome and Soft-Tissue Pathology.

  • Potential role of multislice SPECT/CT in impingement syndrome and Soft-Tissue Pathology of the ankle and foot.
    Nuclear Medicine Communications, 2013
    Co-Authors: Sugam Chicklore, Gopinath Gnanasegaran, Sanjay Vijayanathan, Ignac Fogelman
    Abstract:

    INTRODUCTION Impingement syndrome and Soft-Tissue Pathology have been recognized as significant causes of chronic ankle pain. Conventional bone scintigraphy was traditionally used for osseous Pathology, but with the advent of single photon emission computed tomography/computed tomography (SPECT/CT) the role of bone scintigraphy in these patients is being reconsidered. AIM The aim of this study was to assess the potential role of multislice SPECT/CT in diagnosing impingement syndrome and Soft-Tissue Pathology of the ankle and foot. MATERIALS AND METHODS A total of 209 patients (age range: 19-80 years) underwent a two-phase Tc-99m methylene diphosphonate bone scan followed by SPECT/CT between 2006 and 2009 for various ankle and foot pathologies. These scans were reviewed for impingement syndrome and Soft-Tissue Pathology. The diagnosis made on SPECT/CT was compared with the clinical diagnosis, and two-phase bone scan findings and additional findings obtained from SPECT/CT were noted. RESULTS Out of the 209 patients, 43 (21%) were diagnosed with impingement syndrome or Soft-Tissue Pathology. Clinical diagnosis versus bone SPECT/CT: in 24/43 (56%) patients, SPECT/CT provided information not suspected on clinical diagnosis. In 19/43 (44%) patients, SPECT/CT confirmed the clinical diagnosis. Two-phase bone scan versus SPECT/CT: in 31/43 (72%) patients, SPECT/CT provided additional information, which was not diagnosed on the conventional two-phase bone scan. The findings of the two-phase bone scan and SPECT/CT were concordant in 12/43 (28%) patients. CONCLUSION Tc-99m methylene diphosphonate bone SPECT/CT is useful in localizing and characterizing impingement syndrome and Soft-Tissue Pathology in patients with ankle/foot pain. SPECT/CT may complement MRI and ultrasonography in the investigation of impingement syndrome and Soft-Tissue Pathology.

Kyle Perry - One of the best experts on this subject based on the ideXlab platform.

  • Grading, Staging, and Reporting of Soft Tissue Tumors
    Soft Tissue Pathology for Clinicians, 2017
    Co-Authors: Kyle Perry
    Abstract:

    In addition to the histologic diagnosis, Soft Tissue neoplasms manifest other characteristics that can stratify tumor behavior and impact treatment, such as tumor grade and stage. In the realm of Soft Tissue Pathology, differentiation of the tumor, mitosis and necrosis are utilized to assign grade. The extent and size of tumor are employed to assign pathologic stage. Familiarity with these elements and the structure of a surgical Pathology report can help ensure successful collaboration between the pathologist and other members of the treatment team.

  • Critical Concepts in Soft Tissue Pathology
    Soft Tissue Pathology for Clinicians, 2017
    Co-Authors: Kyle Perry
    Abstract:

    With recent advances in interventional radiology, the diagnosis of Soft Tissue neoplasms is increasingly made on image-guided needle core biopsies. This less invasive technique is often preferred to an open biopsy procedure; however, appropriate specimen handling and communication are critical in ensuring a successful pathologic diagnosis with such limited Tissue. Wide excision, often after neoadjuvant radiation or chemotherapy, is the common surgical approach for intermediate- to high-grade sarcomas. In these resection specimens, the pathologist typically assesses the tumor for characteristics such astreatment effect, depth of invasion, and involvement of the surgical margins.

  • Histologic Examination and Ancillary Studies in Soft Tissue Pathology
    Soft Tissue Pathology for Clinicians, 2017
    Co-Authors: Kyle Perry
    Abstract:

    After reviewing the clinical history, a pathologist will typically assess the microscopic features of a tumor on an H&E slide to generate a differential diagnosis from which ancillary tests are ordered. Common ancillary tests include immunohistochemical stains, conventional karyotyping, fluorescence in situ hybridization, and reverse transcription PCR, among others. In addition to these studies, pathologists can freeze, section, and examine representative Tissue during an operative procedure and render a preliminary diagnosis to the surgeon. Understanding the uses and limitations of these tests can help the clinician fully leverage the services of the Pathology lab in the diagnosis and care of patients with Soft Tissue sarcomas.